Molbio Diagnostics
Developer and manufacturer of portable molecular diagnostic platforms and test kits focused on infectious disease screening and point-of-care deployment in low-resource settings. Described activities include chip-based real-time PCR assay development, clinical validation with national institutions, field deployment and outreach testing programs, and domestic kit manufacturing.
Industries
Nr. of Employees
Very Large (1000+)
Molbio Diagnostics
Products
Portable molecular diagnostic platforms
Compact instruments designed for point-of-care molecular testing and capable of operation in settings with limited infrastructure.
Chip-based RT-PCR test kits for HPV screening
Indigenously produced HPV test kits using chip-based RT-PCR intended for rapid, affordable screening of high-risk HPV genotypes.
Truenat
A novel multi-disease real-time PCR platform designed to decentralize and expand access to accurate diagnostics with gold-standard molecular tests at the point of care. Fully automatic, battery-operated, and portable, ideal for diverse healthcare settings from urban hospitals to remote health facilities.
Truenat® MTB Plus
A rapid molecular test launched by Molbio Diagnostics for diagnosis of active TB. It is a portable, battery-operated, chip-based test which detects Mycobacterium tuberculosis (MTB) in approximately 1 hour and rifampicin (RIF) resistance in another 40–60 minutes.
Truenat® HIV-1/HIV-2
Chip based Real Time Duplex PCR Test (RT-PCR) for the quantitative detection and diagnosis of Human Immunodeficiency Virus Type 1 & 2 (HIV-1 & 2) in whole Blood / Plasma / Serum and aids in the monitoring of the HIV-1 & 2 viral load of patients with infection. Runs on the Truelab® Real Time micro PCR Analyzers.
Truenat MTB - INH
Chip-based Real Time PCR Test for Isoniazid Resistant Mycobacterium tuberculosis.
Portable molecular diagnostic platforms
Compact instruments designed for point-of-care molecular testing and capable of operation in settings with limited infrastructure.
Chip-based RT-PCR test kits for HPV screening
Indigenously produced HPV test kits using chip-based RT-PCR intended for rapid, affordable screening of high-risk HPV genotypes.
Truenat
A novel multi-disease real-time PCR platform designed to decentralize and expand access to accurate diagnostics with gold-standard molecular tests at the point of care. Fully automatic, battery-operated, and portable, ideal for diverse healthcare settings from urban hospitals to remote health facilities.
Truenat® MTB Plus
A rapid molecular test launched by Molbio Diagnostics for diagnosis of active TB. It is a portable, battery-operated, chip-based test which detects Mycobacterium tuberculosis (MTB) in approximately 1 hour and rifampicin (RIF) resistance in another 40–60 minutes.
Truenat® HIV-1/HIV-2
Chip based Real Time Duplex PCR Test (RT-PCR) for the quantitative detection and diagnosis of Human Immunodeficiency Virus Type 1 & 2 (HIV-1 & 2) in whole Blood / Plasma / Serum and aids in the monitoring of the HIV-1 & 2 viral load of patients with infection. Runs on the Truelab® Real Time micro PCR Analyzers.
Truenat MTB - INH
Chip-based Real Time PCR Test for Isoniazid Resistant Mycobacterium tuberculosis.
Services
Mobile and community-based implementation of molecular testing programs to expand access in remote and resource-limited areas.
Mobile and community-based implementation of molecular testing programs to expand access in remote and resource-limited areas.
Expertise Areas
- Point-of-care molecular diagnostics
- Infectious disease screening (tuberculosis, HPV)
- Assay development and genotype-specific detection
- Clinical validation and performance evaluation
Key Technologies
- Chip-based real-time PCR (RT-PCR)
- Portable/battery-operable molecular instruments
- Genotype-specific molecular assays
- Point-of-care testing workflows
News & Updates
Announcement describing indigenous chip-based RT-PCR HPV test kits validated by national institutions and intended for point-of-care screening of multiple high-risk HPV genotypes.
Field report on deployment of a compact molecular diagnostic instrument in rural Kenya, reporting increased case detection and use in outreach activities.
Announcement describing indigenous chip-based RT-PCR HPV test kits validated by national institutions and intended for point-of-care screening of multiple high-risk HPV genotypes.
Field report on deployment of a compact molecular diagnostic instrument in rural Kenya, reporting increased case detection and use in outreach activities.